Last reviewed · How we verify
Vicagrel and omeprazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vicagrel and omeprazole (Vicagrel and omeprazole) — Jiangsu vcare pharmaceutical technology co., LTD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vicagrel and omeprazole TARGET | Vicagrel and omeprazole | Jiangsu vcare pharmaceutical technology co., LTD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vicagrel and omeprazole CI watch — RSS
- Vicagrel and omeprazole CI watch — Atom
- Vicagrel and omeprazole CI watch — JSON
- Vicagrel and omeprazole alone — RSS
Cite this brief
Drug Landscape (2026). Vicagrel and omeprazole — Competitive Intelligence Brief. https://druglandscape.com/ci/vicagrel-and-omeprazole. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab